169 related articles for article (PubMed ID: 11251949)
1. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.
Fröhlich E; Schlagenhauff B; Möhrle M; Weber E; Klessen C; Rassner G
Cancer; 2001 Mar; 91(5):972-82. PubMed ID: 11251949
[TBL] [Abstract][Full Text] [Related]
2. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
Qian F; Bajkowski AS; Steiner DF; Chan SJ; Frankfater A
Cancer Res; 1989 Sep; 49(17):4870-5. PubMed ID: 2758418
[TBL] [Abstract][Full Text] [Related]
3. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
4. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
8. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.
Becker B; Multhoff G; Farkas B; Wild PJ; Landthaler M; Stolz W; Vogt T
Exp Dermatol; 2004 Jan; 13(1):27-32. PubMed ID: 15009113
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
Sloane BF; Honn KV; Sadler JG; Turner WA; Kimpson JJ; Taylor JD
Cancer Res; 1982 Mar; 42(3):980-6. PubMed ID: 7059993
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
11. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
13. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
14. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
16. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
17. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential.
Qian F; Chan SJ; Achkar C; Steiner DF; Frankfater A
Biochem Biophys Res Commun; 1994 Jul; 202(1):429-36. PubMed ID: 8037744
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma.
Ding Y; Prieto VG; Zhang PS; Rosenthal S; Smith KJ; Skelton HG; Diwan AH
Cancer; 2006 Mar; 106(5):1123-9. PubMed ID: 16456815
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
